corporate presentation - stabicon
TRANSCRIPT
Corporate Presentation
Contoso Ltd.2
Stability Center
2010
2012
2013
2014
2015
2016
2017
2018
2019
Health Canada Approval
WHO(Geneva),ISO –17025,Product Certification Center
Bio WavierDivision
Formulation Development Center
Platform Technology Center
Metabolism & Infection(AMR)
Commercialization of Technology
Clinical Supply
History
www.stabicon.com
Started Operation
Contoso Ltd.3
www.stabicon.com
Division
43
21 STRATEGIC PARTNERING
Market Expansion, Product line
expansion, Technical Expertise &
Co Development
TRANSACTIONAL
TECHNOLOGY
Niche dosage (Nasal, Topical & Oral),
Preservative Free, Nano Form,
Therapeutic Area, Wellness, Pain
Management, Hygiene products and
complex product dosage category
MANUFACTURING
Specialized Product Manufacturing
Stability, Formulation, Analytical
Research, Invitro Studies and
Integrated services
Contoso Ltd.4
• Specialized in managing product quality process, upgradingand introducing advanced technology into products. we areproud to lay a foundation for prosperous future inprevention and cure segment, future medicine & FMCGbusiness.
• Established in September 2010.
• Team experience spans across from design to concept, lab to commercialization of product and with competent technical experts.
• Automated Process driven and prepared for integration withpartner site for transparency and real time access on eachapplication.
Overview
www.stabicon.com
Contoso Ltd.
Audited and approved by WHO, Geneva01
Accredited by ISO / IEC17025:2005 (NABL)
Approved by Health Canada
Registered with DSIR
2
1
3
4
5
6
02
03
04
05
06
Approved by FDA (India)
Registered with US FDA
5
Regulatory Compliance
www.stabicon.com
Contoso Ltd.6
• Professional Management with a strength of 100+ scientists.
• Strong management governance
• Lean Organization - quicker decision
• Integration functional area expertise under one umbrella
• Easy to scale up or modify as most of process are automated
• State of art infrastructure
• Compliant with EHS regulations
Infrastructure
www.stabicon.com
Contoso Ltd.7
Unmet needs- Therapeutic Solution
www.stabicon.com
Non – Conventional Approach Reduce Development window
& Dosage Optimization
Contoso Ltd.
Value CreationStrengthening
manufacturing excellence &
process transformation
initiatives
Automation Initiatives
in the value chain
Facilitating Development of
An Innovation Portfolio
Designing of World Class
Facilities and Developing
Robust Infrastructure
Dedicated Center - Project
8www.stabicon.com
Contoso Ltd.9
Platform Technology
www.stabicon.com
• Effective Delivery Designing Model concept to reduce toxicity, & improve delivery
• Lymphatic Transport System Delivery – by pass first phase metabolism.
• Preservative Free
• Improving Solubility & Bioavailability for Class II & IV category technology.
• Control Release using trigger such as time, pH ,temp & moisture to deliver actives more specific profiles, such as pulsatile and delayed release
• Improving delivery of sensory, taste & colour substance.
Contoso Ltd.10
Consumer /OTC - Products
www.stabicon.com
Change Management Technology Migration Quality Assessment and
Review Troubleshooting/Defect
Analysis
Pre – study Concept Design and Ideation Detailed Design and Analysis Final Design After Sales
Performance Improvement Benchmarking Manufacturing Process Optimization Value Engineering
Knowledge Based Engineering Design Automation Data and Model Recognition from Documents
Product Lifecycle
Product Sustenance
Growth SolutionAutomation
Contoso Ltd.11
Prescription (Rx)– Products
www.stabicon.com
Combinations Improve
Activity
Formulation or dosage form
Route of Administration Oral, Transdermal , Inhalation or Injectable
Complex ActiveIngredients
Complex Formulation
Complex Root ofDelivery
Complex Drug-Device
Combination
Prototype Validation Study Clinical Study
Regulatory –Dossier
Submission
Contoso Ltd.12
Formulation & Development Bio waiver AMR - HTS
Microbial Studies
Platform Technology
Product & Device Certification
Centralized Stability
Clinical Supply Referral lab & Turn KeyBrand
Services Suite
www.stabicon.com
Contoso Ltd.13
Business Solution
www.stabicon.com
Contoso Ltd.
CanadaEurope
United States
Asia
Africa
14
Our Client base
www.stabicon.com
Thank YouBusiness Development
+91 80 41250324
[email protected], [email protected]
www.Stabicon.com
© 2020, Stabicon Life Sciences Pvt. Ltd. All Rights Reserved.